Rev Genomics Revenue and Competitors
Estimated Revenue & Valuation
- Rev Genomics's estimated annual revenue is currently $930k per year.
- Rev Genomics's estimated revenue per employee is $155,000
Employee Data
- Rev Genomics has 6 Employees.
- Rev Genomics grew their employee count by 0% last year.
Rev Genomics's People
Name | Title | Email/Phone |
---|
Rev Genomics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Rev Genomics?
We are an Oakland, California, plant biotechnology company utilizing cutting edge breeding tools for high-value crops. Our toolkit includes whole genome selection, advanced tissue culture, molecular genetics and in-house metabolite analytics. With our scientific approach to Cannabis strain development we have created new strains now being commercialized in the legal California market. We are backed by Y-Combinator and our platform has been featured in TechCrunch.
keywords:N/AN/A
Total Funding
6
Number of Employees
$930k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Rev Genomics News
The Cycas genome contains four homologues of the fitD gene family that were likely acquired via horizontal gene transfer from ... Plant Rev.
The use of whole-genome sequencing (WGS) for bacteria, ... E. E. Long-read human genome sequencing and its applications. Nat. Rev. Genet.
Miga, K. H. & Wang, T. The need for a human pangenome reference sequence. Annu. Rev. Genomics Hum. Genet. 22, 81102 (2021). Article CAS...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 6 | 0% | N/A |
#2 | $0.4M | 6 | -14% | N/A |
#3 | $0.4M | 6 | -14% | N/A |
#4 | $0.4M | 6 | -14% | N/A |
#5 | $0.4M | 6 | 0% | N/A |